Z Squared Completes Business Combination with Coeptis Therapeutics and Lists on Nasdaq Global Market

Key Highlights for Investors

• Business Combination Completed: Z Squared, Inc., a vertically integrated computing infrastructure company, has officially completed its business combination with Coeptis Therapeutics Holdings, Inc. The combined entity will operate under the name “Z Squared” and commence trading on the Nasdaq Global Market under the ticker symbol ZSQR starting Monday, April 27, 2026 (CUSIP: 98878K108).
• Share Structure and Ownership: Post-combination, approximately 51 million shares of common stock are outstanding. Importantly, former stockholders of Z Squared now own approximately 85% of the combined company, with existing Coeptis stockholders holding about 15%. This significant shift in ownership structure is highly relevant for investors assessing future influence and control.
• Distribution to Coeptis Shareholders: Prior to closing, Coeptis effected a pro rata distribution to its record date stockholders of its ownership interest in a subsidiary holding a portion of its pre-business combination biopharmaceutical business. This means legacy Coeptis holders received a direct benefit and are ring-fenced from the new computing infrastructure focus of Z Squared.
• Vertically Integrated Platform: Z Squared operates advanced computing equipment across North Carolina, South Carolina, and Iowa, supported by dynamic power management, real-time analytics, and a comprehensive hardware lifecycle management program. The company emphasizes operational resilience, efficiency, and rapid scalability. This infrastructure is designed to minimize reliance on single providers and increase flexibility in response to shifting power costs and grid conditions.
• Strategic Positioning: Z Squared’s business model is designed to reduce exposure to localized disruptions (regulatory, grid instability) and enable rapid scaling into new geographies and emerging computing workloads. The company actively manages power consumption to respond to grid pricing signals, aiming to lower costs while maximizing uptime and operational efficiency.
• Experienced Leadership: The company is led by a team with deep expertise in large-scale computing operations, infrastructure optimization, and power management.

Potential Price Sensitive Information and Shareholder Considerations

• Change in Business Focus: With the separation of Coeptis’s legacy biopharmaceutical operations and the transition to a computing infrastructure company, shareholders should be aware that the combined company’s future is now fully committed to advanced computing and not pharmaceuticals. This fundamental shift could significantly impact the investment thesis and share valuation.
• Ownership Realignment: The new ownership breakdown—with Z Squared stockholders holding a vast majority—may influence future strategic decisions, board composition, and voting outcomes.
• Nasdaq Listing: Commencing trading on the Nasdaq Global Market as ZSQR enhances visibility, liquidity, and potentially attracts new institutional investors, which could prove price accretive.
• Forward-Looking Risks: The company cautions about significant risks and uncertainties, including the ability to execute its business strategy, competition, volatility in power costs and digital asset values, hardware availability and obsolescence, and regulatory developments. Such factors could materially impact future share price and performance.

Management Commentary

Michelle Burke, Chief Operating Officer, stated, “We have built a vertically integrated computing infrastructure platform across three states, supported by dynamic power management, real time analytics, and a comprehensive hardware lifecycle program. Z Squared is well positioned to deliver consistent results and to grow into new geographies and workloads. We could not be more excited about what lies ahead. The market timing is exceptional, and we believe the best is yet to come.”

About Z Squared

Z Squared operates a distributed, facility-agnostic computing infrastructure that is purpose-built for resilience and rapid scaling. Its power strategy adapts to real-time grid conditions and pricing signals, aiming to keep costs low while maintaining operational efficiency. The company’s infrastructure is supported by in-house repair, lifecycle management, and real-time analytics, reducing capital waste and exposure to localized risks.

For more information, investors can visit: www.zsquaredinc.com

Investor Relations Contact

Email: [email protected]

Disclaimer: This article contains forward-looking statements subject to risks and uncertainties, including but not limited to execution of business strategy, competition, energy regulation, hardware lifecycle, and market conditions. Actual results may differ materially from those anticipated. Investors should review all company filings and consult their financial advisor before making investment decisions.

View Coeptis Therapeutics Holdings, Inc. Historical chart here